Panic disorder can upend a life that looked steady from the outside. People describe a sudden surge of dread, a pounding heart, tight chest, shallow breaths, and a sense that something catastrophic is happening. On paper these are symptoms, in a body they feel like a threat. Many patients land in emergency departments convinced they are having a heart attack. When the workup is negative yet the episodes keep coming, the goal shifts from ruling out disease to building a strategy that returns control. Medication can play a central role when used thoughtfully, often alongside targeted psychotherapy.
I have managed hundreds of patients with panic disorder in primary care clinics, specialty practices, and collaborative care programs connected to larger mental health services. Panic responds to treatment. Getting there depends on matching the right option to the right person, pacing the dose changes carefully, and setting realistic expectations about timeframes and side effects. This article walks through the current evidence and practical decision points clinicians and patients face.
What we are treating, and how to know
Panic disorder involves recurrent, unexpected panic attacks accompanied by persistent concern about additional attacks or their consequences, or significant changes in behavior to avoid them. Attacks peak within minutes and include at least a handful of symptoms like palpitations, sweating, trembling, shortness of breath, chest discomfort, nausea, chills, dizziness, derealization, fear of losing control, or fear of dying.
Before committing to psychiatric medication, clinicians should check for medical contributors. Hyperthyroidism, arrhythmia, asthma, hypoglycemia, pheochromocytoma, seizure disorders, and stimulant or cannabis use can mimic or compound panic. In the urgent care setting, an ECG and basic labs may be appropriate based on the story and risk factors. Careful history matters more than a battery of tests. If attacks began after a traumatic event, or if nightmares and intrusive memories dominate, consider comorbid PTSD and the potential need for trauma therapy in addition to panic-focused approaches.
Why medication helps
Panic is a false alarm in the body’s threat system. Medications that raise serotonergic and noradrenergic tone reduce the sensitization of brain circuits that overreact to normal bodily sensations like a skipped beat or a quick breath. While no pill erases vulnerability to stress, the right dose can lower the volume enough for exposure based psychotherapy to work, reduce anticipatory anxiety, and allow people to reclaim routines like driving or grocery shopping.
Across randomized controlled trials, selective serotonin reuptake inhibitors, several serotonin norepinephrine reuptake inhibitors, and certain tricyclic antidepressants outperform placebo for reducing attack frequency and severity, often by week 4 to 6. Many trials ask participants to keep panic diaries, which show a typical pattern: fewer attacks, shorter peaks, and reduced avoidance. Effect sizes are moderate, which in real life translates to meaningful relief for a majority and full remission for a substantial minority. The number needed to treat for one person to achieve response, depending on the specific drug and study, lands between roughly four and six. Those are respectable odds, especially when medication is combined with cognitive behavioral therapy.
First line options and how they differ
SSRIs remain the backbone of pharmacotherapy for panic disorder. Venlafaxine XR, an SNRI, has similar support. Clinicians often choose based on side effect profiles, coexisting depression, sleep issues, and drug interactions. Dose matters, but in panic disorder, sensitivity to activating effects also matters, so most people do better with a low starting dose and a slower build than we might use for depression.
Here is a compact comparison I share in clinic when choosing a first option:
- Sertraline: Versatile, good for comorbid depression and social anxiety. Start 12.5 to 25 mg daily, advance by 12.5 to 25 mg every 1 to 2 weeks, usual range 50 to 150 mg. Can cause GI upset early, often settles with food and time. Escitalopram: Clean interaction profile, often well tolerated. Start 5 mg, move to 10 mg after 1 to 2 weeks, range 10 to 20 mg. Less activating for many, watch for sexual side effects and fatigue. Fluoxetine: Long half-life, smoother taper later. Start 5 to 10 mg, range 10 to 40 mg. Can be energizing, useful when low energy dominates, but go slow in highly anxious patients. Paroxetine: Effective but more anticholinergic effects and weight gain, and higher risk of discontinuation symptoms. Start 5 to 10 mg, range 10 to 40 mg. Often avoided in perinatal mental health unless clearly indicated. Venlafaxine XR: Evidence based for panic, especially helpful when depression is stubborn. Start 37.5 mg, increase to 75 mg after 1 to 2 weeks, range 75 to 225 mg. Watch for blood pressure increases at higher doses and discontinuation symptoms if doses are missed.
Duloxetine has robust data in depression and generalized anxiety, but less in pure panic. It can still help the right person, particularly if chronic pain is part of the picture. That intersection comes up more than people think. Patients with fibromyalgia or neuropathic pain often carry a higher load of anxiety symptoms. Using one medicine that helps both pain management and panic can simplify a regimen and improve adherence.
What response looks like and when to adjust
With a careful ramp, early side effects like jitteriness, queasy stomach, and sleep disruption usually fade in the first week or two. True panic reduction tends to show up between weeks 3 and 6. If there is no change at all by week 4 despite adherence, consider a dose increase. Many people need to reach the middle of the usual range for best results. If activation is strong despite a low dose, pausing at that dose for an extra week or adding a small dose of hydroxyzine at bedtime for a few days can help someone stay the course.
Sexual side effects are the most common reason I hear for wanting to stop. Lowering the dose can help but sometimes costs efficacy. Alternatives include switching to another SSRI with fewer personal side effects, trying an SNRI, or moving to mirtazapine, which is not first line for panic based on trials but can calm anxiety and improve sleep in selected patients. Bupropion tends to be activating and may worsen panic in some, so I rarely choose it for this diagnosis unless depression is dominant and past history suggests it helped.
Benzodiazepines, used with care
Benzodiazepines reduce panic quickly. For people in the middle of frequent, severe attacks, a short course can be a bridge while an SSRI or SNRI takes effect. The problems are dependency potential, tolerance, cognitive dulling, falls in older adults, and the way these medications can accidentally undercut exposure therapy by preventing someone from learning that panic symptoms are survivable. For these reasons, I reserve benzodiazepines for time limited use, at the lowest effective dose, with a specific plan for taper.
Short acting agents like alprazolam can produce quick relief but also more rebound anxiety between doses. Longer acting options like clonazepam can smooth that out. Even then, I discuss a two to four week window and a taper plan from the start. If a patient has a history of substance use disorder, I look for other options entirely.
TCAs and MAOIs, still relevant but less used
Imipramine reduced panic attacks long before SSRIs arrived. It remains effective, especially when first line options fail, but anticholinergic side effects and cardiac conduction risks make it a second line choice. Clomipramine can be particularly useful when obsessive features are present. Both require slow titration, baseline ECG in certain patients, and careful attention to drug interactions.
MAOIs like phenelzine can be powerful for refractory cases, yet the dietary restrictions and risk of hypertensive crisis limit their use to subspecialty care. In real world practice, I might consider them when panic coexists with severe atypical depression that has not budged after several standard trials, and when a patient is committed to the restrictions.
What about buspirone, beta blockers, and hydroxyzine
Buspirone does not have strong evidence for panic disorder. It helps generalized anxiety in some people, but when I have tried it for panic the results are usually modest at best. Beta blockers shine in performance anxiety by dampening tremor and heart rate during a predictable event, but they do not reliably prevent spontaneous panic. Hydroxyzine can take the edge off at night or during the first week of an SSRI start, though sedation is common. Pregabalin has supportive evidence for generalized anxiety and mixed results in panic; it is not a go to for this diagnosis in my practice, but occasional patients with prominent somatic tension find it calming.
Medication and psychotherapy work better together
Cognitive behavioral therapy tailored to panic, with interoceptive exposure, is a top tier treatment. It teaches the brain to reinterpret bodily sensations and breaks the cycle of avoidance. When I combine CBT with an SSRI or venlafaxine, outcomes improve. Medication lowers the baseline anxiety enough for people to do the hard work of exposure. Therapy, in turn, reduces the chance of relapse when a medication is tapered later.
If panic sits on a foundation of trauma, I add trauma therapy once panic is stable enough for the person to sleep, eat, and engage. Stabilization first, then gradual, well supported trauma processing. Therapies like cognitive processing therapy or EMDR can be integrated without losing ground on panic gains, but timing and collaboration among clinicians matter.
Special considerations across life stages and health contexts
Perinatal mental health brings unique trade offs. Untreated panic in pregnancy can disrupt prenatal care, sleep, and nutrition. It also increases the risk of postpartum mood disorders. Sertraline and escitalopram are often favored because of tolerability and relatively reassuring reproductive safety data. Paroxetine is commonly avoided in early pregnancy due to a small signal for cardiac malformations. In lactation, sertraline has minimal transfer into breast milk and is a frequent first choice. Every decision involves shared judgment about severity, past response, and nonpharmacologic supports. A good perinatal psychiatry consult can ground the plan in up to date data and help a family feel confident.
Adolescents can present with panic that looks like school refusal or sudden avoidance of sports. Medication can help, but I lead with CBT when possible, add an SSRI at lower starting doses, and involve parents in exposure planning. Older adults often carry cardiac or pulmonary comorbidities that complicate the picture. SSRIs still work, but I avoid paroxetine because of anticholinergic effects and select doses with fall risk in mind. Benzodiazepines are a last resort in this group.
Chronic pain can feed panic, and panic can amplify pain. SNRIs like duloxetine or venlafaxine may help both, reducing polypharmacy. Opioids and benzodiazepines together raise overdose risk, so I avoid that combination and coordinate with pain management teams. For patients with IBS, sertraline may be easier on constipation than paroxetine, but diarrhea can appear early. Dietary adjustments and soluble fiber sometimes solve that without a switch.
Patients using cannabis to self treat anxiety often report short term relief but worse baseline anxiety between uses. High THC products can trigger panic attacks. I discuss this openly, frame it as an experiment in physiology rather than a moral judgment, and support gradual reduction while we build treatments that last.
Ketamine therapy and panic disorder
Intravenous or intranasal ketamine therapy has strong momentum in treatment resistant depression and is being explored in PTSD. For primary panic disorder, the evidence is nascent. A few small studies and case series suggest rapid anxiolytic effects, but durability is uncertain and relapse common without ongoing sessions. Dissociation during administration can be uncomfortable for people whose core fear is losing control. In my practice, I consider ketamine only when panic coexists with severe, refractory depression or PTSD, after standard therapies have failed, and within a program that monitors blood pressure, substance use risk, and dissociative symptoms. It remains an off label, specialized tool, not a first line option for panic.
Building a stepwise medication plan
A good plan starts with goals. Some patients want zero attacks; others want to drive without white knuckles and sleep through the night. We set milestones, then pick a medication that fits the person’s history. If a sibling did well on sertraline, that matters. If someone tried fluoxetine years ago and felt wired, I pick a gentler start.
Starting low and going slow is not just a slogan in panic disorder. For sertraline, I might begin at 12.5 mg daily for one week, then 25 mg, then 37.5 or 50 mg, checking in weekly by portal or phone. I warn that the first few days can be bumpy, and I offer specific aids: take with breakfast, skip the second coffee, walk after lunch to bleed off restlessness, use diaphragmatic breathing twice a day whether or not you feel anxious. Small behavioral anchors keep people engaged when motivation sags.
I schedule a formal reassessment at four to six weeks. If there is partial improvement, we climb by one step. If there is no change and side effects are mild, I still increase once more before calling it a failed trial. Most drugs deserve 6 to 8 weeks at a therapeutic dose. If adherence is patchy, we troubleshoot. Pharmacy synchronization, pillboxes, texts, and shifting doses to times that fit the person’s day matter as much as milligrams.
When response is solid, we keep the dose steady for at least 12 months. Panic has a tendency to flare under stress, and stopping too soon sets that up. Maintenance reduces relapse. During that year, we reinforce CBT skills and exposure practice so that the medication is not doing all the work. When life is relatively stable for a few months and the person is using skills consistently, we discuss tapering.
Tapering SSRIs and SNRIs requires patience. Many people can reduce by about 10 to 25 percent of the dose every two to four weeks. If discontinuation symptoms appear, like brain zaps, dizziness, irritability, or a swirl of brief anxiety spikes, we pause or step back to the prior dose. Fluoxetine’s long half-life usually makes this smoother. Venlafaxine and paroxetine require the most care. If panic symptoms return in a sustained way rather than blips during a stressful week, that signals the need to resume the effective dose and continue maintenance longer.
Managing setbacks and edge cases
Occasionally, a patient reports more frequent panic after starting an SSRI despite a gradual titration. If the increase is modest and early, I wait a week or two unless distress is high. For severe activation, I either reduce to the last calm dose or switch within class. Some individuals do better with escitalopram after struggling on sertraline, or vice versa. If two attempts with different SSRIs produce the same pattern, venlafaxine can work better, and mirtazapine at night can help calm activation while a daytime SSRI continues.
Cardiac sensations are a common trigger. If palpitations dominate, getting a basic cardiac evaluation can free the mind from that worry and make interoceptive exposure possible. Beta blockers can occasionally help a narrow subgroup whose main symptom is adrenergic surge without cognitive fear, but pure panic rarely fits that profile. More often, learning to invite and ride out a racing heart in a controlled exposure exercise does more than any pill.
When agoraphobia is severe, I sometimes begin medication while arranging home based or telehealth CBT. People can start early exposures in low risk settings, such as standing on the porch for five minutes with focused breathing, before working up to bus rides or crowded stores. Small wins build momentum, and medication helps them land.
The role of collaborative care and access to services
Many people with panic receive care in primary care clinics. Integrated behavioral health programs, where a care manager tracks symptoms and a consulting psychiatrist advises the primary clinician, raise remission rates. Telehealth expanded access, and for panic this format works well. Panic diaries, symptom scales like the PDSS, and brief check ins every two weeks can be handled remotely. When attacks lead to ER use, close outpatient follow up reduces bounce backs.
Large systems often house specialized mental health services that include group CBT for panic, exposure coaching, and medication management. Small communities may rely on a patchwork of resources. I encourage patients to ask their insurer or local health department about programs they might not find on a simple web search. Many universities run training clinics that offer low cost CBT under supervision.
A brief case, and what it teaches
A 34 year old teacher with no psychiatric history developed panic after a respiratory infection. She had two ER visits for chest pain, normal ECGs and troponins, and she stopped driving on the highway. We started sertraline 12.5 mg, planned weekly portal messages, and gave a handout for interoceptive exposure exercises, starting with 30 seconds of paced hyperventilation, then rest, repeated three times, three days per week. She had nausea days two to five, used ginger tea and small meals, then stabilized. At week three, attacks were shorter. We increased to 50 mg. She practiced exposures with a colleague sitting nearby after school. By week eight she took a short highway drive at 9 a.m. With light traffic. We held 75 mg through the school year, then spent the summer at the same dose with more challenging exposures. Twelve months after starting, she tapered slowly over three months. Two panic attacks occurred during the taper, both during parent conferences https://jsbin.com/?html,output week. She resumed skills, did not increase medication, and reached zero milligrams on schedule. Two years later, she keeps a short skills refresher routine each Sunday night and remains attack free.
A note on safety planning
Panic is frightening but not dangerous. Still, intense episodes can lead to impulsive medical use or avoidance that harms health, like skipping asthma inhalers for fear of racing heart. I create a simple plan: symptoms to expect, steps to ground the body, and situations that warrant medical evaluation, such as new chest pain with exertion, fainting, or signs of infection. For patients using benzodiazepines, we specify maximum daily doses and a time limited window. Clear plans prevent crises.
Practical conversations to have with your prescriber
- What is the lowest starting dose that makes sense for me, and how will we increase it over time if needed What early side effects might show up in the first two weeks, and how can I manage them without stopping too soon How will we measure progress, and at what point will we consider a dose change or a switch What is the plan for duration of treatment once I respond, and how will we taper to minimize discontinuation symptoms How do my other conditions and medications, including for pain management, affect our choices
Medication management is a relationship, not a prescription
The term medication management can sound transactional, a refill and a checkbox. For panic disorder, it is closer to coaching. The medicine matters, but so does timing, expectation setting, and combining it with the right therapy. Panic teaches people to fear their own physiology. Treatment teaches a different lesson, that a racing heart is a sensation that rises and falls, and that a mind can learn not to chase it with catastrophic thoughts.
Trauma therapy has a place when past events still drive today’s alarm. Ketamine therapy has a cautious, narrow role when depression or PTSD is severe and refractory. Perinatal mental health decisions require extra care and collaboration. Mental health services across settings can support the journey, from a brief primary care visit to a structured CBT group.
None of these choices are one size fits all. The evidence gives us confidence, and lived practice adds the nuance. Start low, be patient, track progress, and do the paired work of exposure. Over time, most people move from bracing against the next attack to noticing long stretches of ordinary life. That is the real measure of success.
Address: 1025 W. Washington St. Ste B, Marquette, MI 49855
Phone: (906) 262-0071
Website: https://www.caughtdreamintherapy.com/
Email: therapyhub@caughtdreamintherapy.com
Hours:
Monday: 9:00 AM - 7:00 PM
Tuesday: 9:00 AM - 7:00 PM
Wednesday: 9:00 AM - 7:00 PM
Thursday: 9:00 AM - 7:00 PM
Friday: 9:00 AM - 7:00 PM
Saturday: 9:00 AM - 7:00 PM
Sunday: 9:00 AM - 7:00 PM
Open-location code (plus code): GHWJ+7X Marquette, Michigan, USA
Map/listing URL: https://maps.app.goo.gl/9UUb5ZeM9ViFupRv9
Embed iframe:
Socials:
https://www.instagram.com/caught.dreamin/
https://www.facebook.com/caughtdreamin/
The practice offers both in-person sessions in Marquette and secure online therapy, giving clients more flexibility around weather, travel, and scheduling.
Services include mental health therapy, trauma therapy, EMDR and Brainspotting, perinatal mental health support, pain management, breathwork, medication management, and other integrative care options.
People in Marquette looking for support with anxiety, depression, trauma, OCD, grief, relationship issues, or life transitions can find a broad range of evidence-based and holistic approaches here.
Caught Dreamin' Therapy emphasizes personalized therapist matching so clients can connect with a provider whose style and experience fit their needs.
The practice serves the Upper Peninsula with a community-centered approach that blends practical mental health support with whole-person care.
For clients who need more flexibility, online sessions make it easier to stay connected to therapy from home, work, or anywhere in Michigan.
To get started, call (906) 262-0071 or visit https://www.caughtdreamintherapy.com/ to reach out through the contact form.
A public Google Maps listing is also available as a location reference for the Marquette office.
Popular Questions About Caught Dreamin' Therapy, LLC
What services does Caught Dreamin' Therapy offer?
Caught Dreamin' Therapy offers mental health therapy, trauma therapy, EMDR and Brainspotting, perinatal mental health support, pain management, breathwork, medication management, ketamine-assisted therapy support, and other integrative wellness services.
Is Caught Dreamin' Therapy located in Marquette, MI?
Yes. The official contact page lists the Marquette office at 1025 W. Washington St. Ste B, Marquette, MI 49855.
Does the practice offer online therapy?
Yes. The official site says the Marquette location offers both in-person therapy sessions and secure online sessions.
Who does the practice work with?
The Marquette location page says the practice supports adults, teens and young adults, children, couples, and perinatal parents.
What issues does Caught Dreamin' Therapy commonly help with?
The official site highlights support for anxiety, OCD, depression, trauma, PTSD, relationship issues, adjustment disorders, grief and loss, pain management, and perinatal mental health challenges.
Does the practice provide EMDR therapy?
Yes. EMDR and Brainspotting are listed among the core specialty therapies on the website.
Does the website list office hours?
I could not verify public office hours on the accessible official pages, so hours should be confirmed before publishing.
How can I contact Caught Dreamin' Therapy?
Phone: (906) 262-0071
Billing: (906) 262-0109
Fax: (989) 267-0230
Email: therapyhub@caughtdreamintherapy.com
Instagram: https://www.instagram.com/caught.dreamin/
Facebook: https://www.facebook.com/caughtdreamin/
Website: https://www.caughtdreamintherapy.com/
Landmarks Near Marquette, MI
Downtown Marquette is a practical reference point for local clients searching for therapy services near the city center. Visit https://www.caughtdreamintherapy.com/ for current service details.
Lake Superior is central to the Marquette identity and helps define the community context the practice serves. Caught Dreamin' Therapy offers both in-person and online support.
Northern Michigan University is one of the best-known landmarks in Marquette and a familiar point of reference for students, staff, and local residents. Call (906) 262-0071 to get started.
Washington Street is a recognizable local corridor and helps orient people looking for the Marquette office location. The official website has the latest contact information.
UP Health System - Marquette is a major healthcare landmark in the area and a useful point of reference for people searching for nearby mental health support. More information is available at https://www.caughtdreamintherapy.com/.
Presque Isle Park is a well-known Marquette destination and helps place the broader local service area for residents and visitors alike. The practice serves Marquette with both in-person and online care.
Mattson Lower Harbor Park is another familiar community landmark for people who know Marquette by its waterfront and downtown spaces. Reach out through the website to ask about availability.
Third Street Village is a recognizable area for many Marquette residents and can help local users understand the surrounding neighborhood context. The practice supports a wide range of therapy needs.
US-41 is a major regional route connecting Marquette with nearby Upper Peninsula communities. Online sessions can also make care more accessible for clients across Michigan.
Black Rocks and the Presque Isle area are widely recognized local landmarks that help define Marquette’s unique setting along Lake Superior. Use the official website to learn more about services and next steps.